In a groundbreaking revelation that challenges long-standing orthopedic practices, a decade-long follow-up study from the Finnish Degenerative Meniscal Lesion Study (FIDELITY) has conclusively demonstrated that partial meniscectomy—a surgical procedure involving trimming of a degenerated meniscus—fails to provide any lasting symptomatic or functional benefits. Contrary to what was once believed, this common intervention not only offers no improvement in patient outcomes but may, in fact, predispose individuals to worsening symptoms, diminished joint functionality, and accelerated osteoarthritic progression.
Partial meniscectomy has been a cornerstone in orthopedic surgery worldwide, adopted widely to alleviate knee pain thought to arise from medial meniscus tears. However, the FIDELITY study’s rigorously controlled design, in which patients were randomly assigned either to undergo the surgery or a sham procedure simulating the operation, provides robust and unprecedented evidence that calls into question the efficacy of this treatment. Patients who underwent the actual meniscal surgery showed more adverse joint outcomes and a higher likelihood of requiring subsequent knee surgeries over a 10-year horizon than those who had the sham intervention.
The central premise that has underpinned partial meniscectomy—that mechanical damage to the meniscus is the primary contributor to medial knee pain—appears to be an oversimplification unsupported by thorough scientific scrutiny. According to Teppo Järvinen, the principal investigator of FIDELITY and professor at the University of Helsinki, this situation exemplifies a phenomenon termed “medical reversal,” where established treatments are overturned by emerging empirical data revealing their ineffectiveness or harm. This deeper understanding urges a reassessment of clinical reasoning previously dominated by biological plausibility rather than rigorous proof.
Adding to this perspective, Raine Sihvonen, co-principal investigator and orthopedic specialist, articulates that joint pain, especially in degenerative conditions of the knee, predominantly arises from complex age-related degenerative changes rather than isolated meniscal tears. This distinguishes the knee from acute mechanical injuries, emphasizing the necessity of distinguishing degenerative pathology from traumas when considering therapeutic interventions.
Over recent years, registry analyses and observational studies flagged potential dangers associated with partial meniscectomy, including not only a heightened risk of knee arthroplasty—a full joint replacement surgery—but also an elevated incidence of postoperative complications. However, such observational evidence, while concerning, did not definitively establish causality. The FIDELITY study’s randomized controlled design directly addresses this gap by elucidating the long-term causal impact of partial meniscectomy on patient outcomes.
Despite accumulating evidence from prior randomized trials indicating no meaningful symptomatic improvement following partial meniscectomy within both short (one to two years) and intermediate (five years) follow-ups, the surgery remarkably remains a widely employed intervention in many health systems worldwide. This persistence even in the face of contradicting evidence exemplifies the inertia inherent in medical practice, where deeply entrenched procedures resist obsolescence even when scientifically disproven.
Clinical guideline recommendations by independent, non-orthopedic bodies have advocated for discontinuation of partial meniscectomy use in degenerative meniscal tears for nearly a decade. Nevertheless, influential orthopedic organizations such as the American Academy of Orthopaedic Surgeons (AAOS) and the British Association for Surgery of the Knee (BASK) have continued to endorse the procedure, underscoring the complex dynamics of changing medical consensus amidst conflicting professional perspectives and patient expectations.
The integrity and robustness of the FIDELITY study owe much to the exemplary collaboration across multiple Finnish university hospitals and healthcare centers, including Helsinki, Kuopio, Turku, Tampere, and Jyväskylä. More impressively, the study maintained extraordinary participant retention, with over 90% of the original cohort of 146 patients engaging in the decade-long follow-up, lending unparalleled strength and reliability to its findings.
These new insights compel the medical community to critically reconsider the role of arthroscopic meniscal surgery within the context of degenerative knee disease. Given the procedure’s apparent ineffectiveness and potential harm, clinicians are encouraged to prioritize non-surgical management and conservative therapies tailored to the multifaceted nature of degenerative joint pain.
Beyond the immediate clinical implications, the study epitomizes the essential movement toward evidence-based orthopedics and surgical practice. By systematically challenging and overturning widely accepted but unsubstantiated practices, it propels forward the cause of patient safety and optimal outcomes, reflecting the highest standards of medical research and ethical patient care.
The FIDELITY study stands as a testament to the critical importance of randomized, placebo-controlled trials in surgical fields, where the placebo effect and procedural biases can profoundly influence outcomes. Its findings underscore a transformative shift away from biologically plausible but unproven interventions toward a science-driven, patient-centered paradigm.
As the global population ages and the burden of degenerative joint diseases escalates, these revelations carry significant public health implications. Reducing ineffective surgeries can not only spare patients from unnecessary risk and complications but also conserve healthcare resources, fostering sustainable and high-value care models.
This landmark study, published in the New England Journal of Medicine and accessible via DOI: 10.1056/NEJMc2516079, heralds a pivotal moment in musculoskeletal medicine. It challenges clinicians, policymakers, and patients alike to re-examine entrenched norms and embrace treatments backed by the highest levels of evidence for the benefit of long-term joint health and quality of life.
Subject of Research: People
Article Title: Arthroscopic Partial Meniscectomy for Degenerative Tear — 10-Year Outcomes
News Publication Date: 29-Apr-2026
Web References: http://dx.doi.org/10.1056/NEJMc2516079
Keywords: Partial meniscectomy, degenerative meniscal tear, arthroscopic knee surgery, osteoarthritis progression, randomized controlled trial, placebo surgery, knee pain, orthopedic surgery, medical reversal, evidence-based medicine, FIDELITY study, joint function.
